Search Within

Gynecologic Medicine Service

Formats
  1. Journal Article (1104)
  2. Meeting Abstract (902)
  3. Review (55)
  4. Book Section (46)
  5. Editorial (36)
  6. Guidelines (22)
  7. Correspondence (9)
  8. Miscellaneous (3)
  9. Research Letter (2)
  10. Book Whole (1)
Groups
  1. Solid Tumor Oncology Division (2180)
  2. Department of Medicine (2174)
  3. Gynecology Disease Management Team (1877)
  4. GDMT, Medicine (1859)
  5. Surgery (603)
  6. GDMT, Surgery (479)

More Groups

People
  1. Carol Aghajanian (615)
  2. Nadeem Abu-Rustum (292)
  3. Martee Hensley (290)
  4. Roisin O'Cearbhaill (273)
  5. Vicky Makker (269)
  6. Paul Sabbatini (262)

More People

Years
  1. 2025 (75)
  2. 2024 (167)
  3. 2023 (171)
  4. 2022 (209)
  5. 2021 (163)
  6. 2020 (203)

More Years

Publications
  1. Journal of Clinical Oncology (458)
  2. Gynecologic Oncology (420)
  3. International Journal of Gynecological Cancer (161)
  4. Annals of Oncology (117)
  5. Clinical Cancer Research (71)
  6. Cancer Research (55)

More Publications

Publishers
  1. American Society of Clinical Oncology (498)
  2. Elsevier B.V. (446)
  3. Lippincott Williams & Wilkins (188)
  4. American Association for Cancer Research (173)
  5. Oxford University Press (144)
  6. Elsevier Inc. (128)

More Publishers

Results (2180)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Principles of antineoplastic therapeutics
    Book Section

    Green, A. K.; Makker, V.
    In Stubblefield, M. D. (Eds.) Cancer Rehabilitation: Principles and Practice. 2nd ed (2019)

    Fulltext@MSK | Save
  • A randomized phase II study of cabozantinib versus weekly paclitaxel in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study
    Journal Article

    Matulonis, U. A.; Sill, M. W.; Makker, V.; Mutch, D. G.; Carlson, J. W.; Darus, C. J.; Mannel, R. S.; Bender, D. P.; Crane, E. K.; Aghajanian, C.
    Gynecologic Oncology (2019)

    Fulltext@MSK | Save
  • Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade
    Journal Article

    Boland, J. L.; Zhou, Q.; Martin, M.; Callahan, M. K.; Konner, J.; O'Cearbhaill, R. E.; Friedman, C. F.; Tew, W.; Makker, V.; Grisham, R. N.; more...
    Gynecologic Oncology (2019)

    Fulltext@MSK | Save
  • Microsatellite instability is associated with the presence of Lynch syndrome pan-cancer
    Journal Article

    Latham, A.; Srinivasan, P.; Kemel, Y.; Shia, J.; Bandlamudi, C.; Mandelker, D.; Middha, S.; Hechtman, J.; Zehir, A.; Dubard-Gault, M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Alisertib in combination with weekly paclitaxel in patients with advanced breast cancer or recurrent ovarian cancer: A randomized clinical trial
    Journal Article

    Falchook, G.; Coleman, R. L.; Roszak, A.; Behbakht, K.; Matulonis, U.; Ray-Coquard, I.; Sawrycki, P.; Duska, L. R.; Tew, W.; Ghamande, S.; more...
    JAMA Oncology (2019)

    Fulltext@MSK | Save
  • Comparison of outcomes in early-stage uterine clear cell carcinoma and serous carcinoma
    Journal Article

    Zhang, M.; Yang, T. J.; Desai, N. B.; DeLair, D.; Kollmeier, M. A.; Makker, V.; Leitao, M. M. Jr; Abu-Rustum, N. R.; Alektiar, K. M.
    Brachytherapy (2019)

    Fulltext@MSK | Save
  • Role of immunotherapy in the management of locally advanced and recurrent/metastatic cervical cancer
    Guidelines

    Dyer, B. A.; Zamarin, D.; Eskandar, R. N.; Mayadev, J. M.
    Journal of the National Comprehensive Cancer Network (2019)

    Fulltext@MSK | Save
  • Clinical trial experience with CA4P anticancer therapy: Focus on efficacy, cardiovascular adverse events, and hypertension management
    Review

    Grisham, R.; Ky, B.; Tewari, K. S.; Chaplin, D. J.; Walker, J.
    Gynecologic Oncology Research and Practice (2018)

    Fulltext@MSK | Save
  • PRECISE: A clinical-grade automated molecular eligibility screening and just-in-time (JIT) physician decision support solution for molecularly-selected oncology trials
    Meeting Abstract

    Tao, J.; Eubank, M. H.; Pamer, E.; Cangemi, N. A.; Drilon, A. E.; Harding, J. J.; Schram, A. M.; Smyth, L. M.; Jhaveri, K. L.; Li, B. T.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase II evaluation of nivolumab, a fully human antibody against PD-1, in the treatment of persistent or recurrent cervical cancer
    Meeting Abstract

    Santin, A.; Deng, W.; Frumovitz, M. M.; Huh, W. K.; Khleif, S.; Lankes, H. A.; Ratner, E.; O'Cearbhaill, R.; Jazaeri, A. A.; Birrer, M.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save